TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cochlear ( (AU:COH) ) has provided an announcement.
Cochlear Limited announced a change in the director’s interest, specifically for Director Diggory William Howitt, who has acquired additional long-term incentive options and performance rights. This change reflects the company’s ongoing commitment to aligning executive interests with long-term performance goals, potentially impacting stakeholder confidence and market perception positively.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$312.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, specializing in implantable hearing solutions. The company focuses on providing innovative products to improve the quality of life for individuals with hearing loss, positioning itself as a leader in the global hearing implant market.
Average Trading Volume: 135,625
Technical Sentiment Signal: Buy
Current Market Cap: A$18.56B
For a thorough assessment of COH stock, go to TipRanks’ Stock Analysis page.